Polish medtech startup BliskoMed announced that entrepreneurs Tomasz and Piotr Karwatka have joined its investor group to support the company’s mission of revolutionizing professional home medical visits.
Archimede, a Sicilian deeptech startup, raised 1.5 million euros in a seed round led by Primo Capital. The company develops ArchMesh, a modular off-grid infrastructure management solution integrating predictive energy management, satellite connectivity, and low-code software. Funds will support scaling and international expansion.
Spanish cleantech company H2SITE, specializing in hydrogen production and separation technologies, has expanded its Series B funding round to over 42 million euros after securing an additional 6 million euros from EIC Fund and a new private investor.
LivingFilters, a Lund University spinout, raised €420K in pre-seed funding led by Turbine Capital to advance AI-designed protein technology for removing PFAS and micropollutants from water. The funds will support pilot projects and product development aligned with EU regulatory mandates.
Hickap, a beauty product startup founded by siblings Wilma and Emil Holmqvist, has closed its books for another record year. The company announced a distribution of ten million kronor to celebrate its success.
Breakits, a fintech company, received millions in investment from a venture capital firm. The article highlights the funding milestone and mentions a breakfast meeting and a profile flying over the Alps.
IndustrialTech startup Almetra secured 16.3 million euros in funding, marking a significant growth milestone for the company.
SegurosIA, a Malaga-based insurtech startup, secured 150,000 euros from Eoniq.fund to advance its AI-driven solutions for the insurance industry.
Atheni AI, a UK startup co-founded by Louise Ballard and Mackenzie Howe, focuses on enabling effective AI adoption in organizations. The company provides coaching and training to help employees use AI tools like ChatGPT and Microsoft Copilot strategically, addressing low adoption rates and fragmented AI usage. After securing £350,000 in funding, Atheni aims to scale its platform that combines personalized AI coaching with analytics to drive behavioral change in workplaces.
Thalia Therapeutics, a UK-based biotech company, raised €3.1 million and acquired Sanmirna Therapeutics, a US-based clinical-stage biotech, to advance its RNA therapeutics pipeline in oncology and cardiovascular disease. The acquisition includes miRisten, a clinical-stage microRNA therapeutic for Acute Myeloid Leukaemia (AML).